These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29439965)

  • 1. Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.
    Talundzic E; Ravishankar S; Kelley J; Patel D; Plucinski M; Schmedes S; Ljolje D; Clemons B; Madison-Antenucci S; Arguin PM; Lucchi NW; Vannberg F; Udhayakumar V
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
    L'Episcopia M; Kelley J; Patel D; Schmedes S; Ravishankar S; Menegon M; Perrotti E; Nurahmed AM; Talha AA; Nour BY; Lucchi N; Severini C; Talundzic E
    Parasit Vectors; 2020 Mar; 13(1):137. PubMed ID: 32171330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Method for Amplicon Deep Sequencing of Drug Resistance Genes in Plasmodium falciparum Clinical Isolates from India.
    Rao PN; Uplekar S; Kayal S; Mallick PK; Bandyopadhyay N; Kale S; Singh OP; Mohanty A; Mohanty S; Wassmer SC; Carlton JM
    J Clin Microbiol; 2016 Jun; 54(6):1500-1511. PubMed ID: 27008882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
    Carnevale EP; Kouri D; DaRe JT; McNamara DT; Mueller I; Zimmerman PA
    J Clin Microbiol; 2007 Mar; 45(3):752-61. PubMed ID: 17121999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a parasite-density based pooled targeted amplicon deep sequencing (TADS) method for molecular surveillance of Plasmodium falciparum drug resistance genes in Haiti.
    Louha S; Herman C; Gupta M; Patel D; Kelley J; Oh JM; Guru J; Lemoine JF; Chang MA; Venkatachalam U; Rogier E; Talundzic E
    PLoS One; 2022; 17(1):e0262616. PubMed ID: 35030215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
    Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
    Hernández DC; Guerra AP; Cucunubá ZM; Nicholls RS; Barrera SM
    Infect Genet Evol; 2013 Aug; 18():183-90. PubMed ID: 23714094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
    Kumar A; Moirangthem R; Gahlawat SK; Chandra J; Gupta P; Valecha N; Anvikar A; Singh V
    Infect Genet Evol; 2015 Dec; 36():190-198. PubMed ID: 26319997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
    Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.